TNGX R&D Expenses
Tango Therapeutics Inc · R&D Expenses
TNGX R&D Expenses
Latest reported$37.20Mperiod ending
TNGX Quarterly R&D Expenses ($10.82M → $37.20M)
Quarterly R&D Expenses
High-resolution chart · PNG
TNGX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 37,199,000 | |
| 33,070,999 | |
| 33,281,000 | |
| 30,815,000 | |
| 32,182,000 | |
| 36,442,000 | |
| 33,937,000 | |
| 33,263,000 | |
| 38,654,000 | |
| 38,065,000 | |
| 31,339,000 | |
| 27,149,000 | |
| 28,671,000 | |
| 28,039,000 | |
| 29,091,000 | |
| 28,744,000 | |
| 23,741,000 | |
| 24,330,000 | |
| 21,634,000 | |
| 21,923,000 | |
| 19,079,000 | |
| 15,000,000 | |
| 15,063,000 | |
| 12,977,000 | |
| 11,129,000 | |
| 10,822,000 |